
Retatrutide (10mg / 20mg / 30mg / 50mg) — Research Peptide
Triple GLP-1 / GIP / Glucagon receptor peptide.
- ≥99% Purity
- Third-Party Tested
- COA With Every Batch
- Cold-Chain Shipping
- For Research Use Only
Retatrutide (CAS 2381089-83-2) is a synthetic research peptide supplied by Eclipse Peptides as a high-purity reference compound for in-vitro laboratory study. It is characterized by the molecular formula C221H343N45O68 and a molecular weight of 4731.4 g/mol, provided as a white lyophilized powder at a minimum purity of >99%.
Retatrutide is studied in the context of metabolic research and remains an active area of scientific investigation. Eclipse supplies Retatrutide strictly as a reference material for research applications. Each batch is third-party tested and ships with a Certificate of Analysis. Store lyophilized at 2–8°C.
This product is for in-vitro research use only. It is not a drug, supplement, or medical product and is not intended for human or animal consumption.
Retatrutide is a synthetic peptide currently being studied for its activity at GLP-1, GIP, and glucagon receptors. It remains an active area of scientific research and investigation.
Retatrutide has been investigated in preclinical and clinical research exploring receptor signaling pathways related to metabolism and energy regulation.
A batch-specific Certificate of Analysis is included with every shipment of this compound. Historical batch COAs are available from our documentation hub.
Request / view COA →- Molecular Formula
- C221H343N45O68
- Molecular Weight
- 4731.4 g/mol
- CAS Number
- 2381089-83-2
- Purity
- >99%
- Appearance
- White lyophilized powder
- Storage
- 2–8°C
- Research Category
- Metabolic
- Product Code
- ECL-RETA